Activation of peripheral κ/δ opioid receptors mediates 15-deoxy-Δ12,14-prostaglandin J2 induced-antinociception in rat temporomandibular joint

Neuroscience

Volumn 163, Issue 4, 2009, Pages 1211-1219

  Pena Dos Santos, D R ^a   Severino, F P ^a   Pereira, S A L ^a   Rodrigues, D B R ^a   Cunha, F Q ^b   Vieira, S M ^b,c   Napimoga, M H ^a   Clemente Napimoga, J T ^a  

^a UNIVERSITY OF UBERABA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO NACIONAL DE PESQUISAS DA AMAZÔNIA   (Brazil)

Author keywords

Opioid receptors; Pain; PGJ2; PPAR gamma; TMJ

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 CHLORO 5 NITROBENZANILIDE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; AMINOGUANIDINE; ARGININE; DELTA OPIATE RECEPTOR; GLIBENCLAMIDE; GUANYLATE CYCLASE; KAPPA OPIATE RECEPTOR; NALOXONE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POTASSIUM CHANNEL BLOCKING AGENT; 15 DEOXYPROSTAGLANDIN J2; 15-DEOXYPROSTAGLANDIN J2; ANALGESIC AGENT; CYCLIC GMP; DRUG DERIVATIVE; FORMALDEHYDE; MU OPIATE RECEPTOR; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN D2; SEROTONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL MIGRATION; CONTROLLED STUDY; DRUG MECHANISM; INHIBITION KINETICS; MALE; NEUTROPHIL; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RAT; TEMPOROMANDIBULAR JOINT DISORDER; ANIMAL; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; INFLAMMATION; METABOLISM; PAIN; SIGNAL TRANSDUCTION; TEMPOROMANDIBULAR JOINT; WISTAR RAT;

ANALGESICS; ANIMALS; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FORMALDEHYDE; INFLAMMATION; KATP CHANNELS; MALE; NITRIC OXIDE SYNTHASE; PAIN; PPAR GAMMA; PROSTAGLANDIN D2; RATS; RATS, WISTAR; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SEROTONIN; SIGNAL TRANSDUCTION; TEMPOROMANDIBULAR JOINT;

EID: 72049110619     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.07.052     Document Type: Article

References (57)

1. Alstergren P, Ernberg M, Kopp S, Lundeberg T, Theodorsson E (1999) TMJ pain in relation to circulating neuropeptide Y, serotonin, and interleukin-1 beta in rheumatoid arthritis. J Orofac Pain 13:49-55.
2. Amarante LH, Duarte ID (2002) The kappa-opioid agonist (+/-)-bremazocine elicits peripheral antinociception by activation of the L-arginine/nitric oxide/cyclic GMP pathway. Eur J Pharmacol 454:19-23.
3. Andersson DA, Gentry C, Moss S, Bevan S (2008) Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress. J Neurosci 28:2485-2894.
4. Bautista DM, Jordt SE, Nikai T, Tsuruda PR, Read AJ, Poblete J, Yamoah EN, Basbaum AI, Julius D (2006) TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 124:1269-1282.
5. Chang CG, Costa E, Brodie BB (1965) Interaction of guanethidine with adrenergic neurons. J Pharmacol Exp Ther 147:303-312.
6. Churi SB, Abdel-Aleem OS, Tumber KK, Scuderi-Porter H, Taylor BK (2008) Intrathecal rosiglitazone acts at peroxisome proliferatoractivated receptor-gamma to rapidly inhibit neuropathic pain in rats. J Pain 9:639-649.
7. Clemente JT, Parada CA, Veiga MC, Gear RW, Tambeli CH (2004) Sexual dimorphism in the antinociception mediated by kappa opioid receptors in the rat temporomandibular joint. Neurosci Lett 372:250-255.
8. Cruz-Orengo L, Dhaka A, Heuermann RJ, Young TJ, Montana MC, Cavanaugh EJ, Kim D, Story GM (2008) Cutaneous nociception evoked by 15-delta PGJ2 via activation of ion channel TRPA1. Mol Pain 4:30.
9. Cunha TM, Verri WA Jr, Schivo IR, Napimoga MH, Parada CA, Poole S, Teixeira MM, Ferreira SH, Cunha FQ (2008) Crucial role of neutrophils in the development of mechanical inflammatory hypernociception. J Leukoc Biol 83:824-832.
10. 2, ligands of the peroxisome proliferator-activated receptor-γ (PPAR-γ), reduce ischaemia/reperfusion injury of the gut. Br J Pharmacol 140:366-376.
11. Dubner R (1991) Basic mechanisms of pain associated with deep tissues. Can J Physiol Pharmacol 69:607-609.
12. Eisenberg E, Vos BP, Strassman AM (1996) The peripheral antinociceptive effect of morphine in a rat model of facial pain. Neuroscience 72:519-525.
13. Ferreira SH, Duarte ID, Lorenzetti BB (1991) The molecular mechanism of action of peripheral morphine analgesia: stimulation of the cGMP system via nitric oxide release. Eur J Pharmacol 201: 121-122.
14. Fiorentino PM, Cairns BE, Hu JW (1999) Development of inflammation after application of mustard oil or glutamate to the rat temporomandibular joint. Arch Oral Biol 44:27-32.
15. Haas DA, Nakanishi O, MacMillan RE, Jordan RC, Hu JW (1992) Development of an orofacial model of acute inflammation in the rat. Arch Oral Biol 37:417-422.
16. Heneka MT, Klockgether T, Feinstein DL (2000) Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J Neurosci 20:6862-6867.
17. Imbe H, Iwata K, Zhou QQ, Zou S, Dubner R, Ren K (2001) Orofacial deep and cutaneous tissue inflammation and trigeminal neuronal activation. Implications for persistent temporomandibular pain. Cells Tissues Organs 169:238-247.
18. Iwata K, Tashiro A, Tsuboi Y, Imai T, Sumino R, Morimoto T, Dubner R, Ren K (1999) Medullary dorsal horn neuronal activity in rats with persistent temporomandibular joint and perioral inflammation. J Neurophysiol 82:1244-1253.
19. Jiang C, Ting AT, Seed B (1998) PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391:82-86.
20. Khasar SG, McCarter G, Levine JD (1999) Epinephrine produces a β-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol 81:1104-1112.
21. Kido MA, Zhang JQ, Muroya H, Yamaza T, Terada Y, Tanaka T (2001) Topography and distribution of sympathetic nerve fibers in the rat temporomandibular joint: immunocytochemistry and ultrastructure. Anat Embryol 203:357-366.
22. Kobayashi K, Fukuoka T, Obata K, Yamanaka H, Dai Y, Tokunaga A, Noguchi K (2005) Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with adelta/c-fibers and colocalization with trk receptors. J Comp Neurol 493:596-606.
23. 2, a neuroprotectant or a neurotoxicant? Toxicology 216:232-243
24. Kopp S (1998) The influence of neuropeptides, serotonin, and interleukin 1beta on temporomandibular joint pain and inflammation. J Oral Maxillofac Surg 56:189-191.
25. Kopp S (2001) Neuroendocrine, immune, and local responses related to temporomandibular disorders. J Orofac Pain 15:9-28.
26. Kwan KY, Allchorne AJ, Vollrath MA, Christensen AP, Zhang DS, Woolf CJ, Corey DP (2006) TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell Transduction. Neuron 50:277-289.
27. Landar A, Zmijewski JW, Dickinson DA, Le Goffe C, Johnson MS, Milne GL, Zanoni G, Vidari G, Morrow JD, Darley-Usmar VM (2006) Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. Am J Physiol Heart Circ Physiol 290:H1777-H1787.
28. Levine JD, Gooding J, Donatoni P, Borden L, Goetzl EJ (1985) The role of the polymorphonuclear leukocyte in hyperalgesia. J Neurosci 5:3025-3029.
29. Levine JD, Taiwo YO, Collins SD, Tam JK (1986) Noradrenaline hyperalgesia is mediated through interaction with sympathetic postganglionic neurone terminals rather than activation of primary afferent nociceptors. Nature 323:158-160.
30. Macpherson LJ, Xiao B, Kwan KY, Petrus MJ, Dubin AE, Hwang S, Cravatt B, Corey DP, Patapoutian A (2007) An ion channel essential for sensing chemical damage. J Neurosci 27:11412-11415.
31. McNamara CR, Mandel-Brehm J, Bautista DM, Siemens J, Deranian KL, Zhao M, Hayward NJ, Chong JA, Julius D, Moran MM, Fanger CM (2007) TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci U S A 104:13525-13530.
32. 2, reduces neutrophil migration via a nitric oxide pathway. J Immunol 180:609-617.
33. 2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor. J Pharmacol Exp Ther 324:313-321.
34. 2-mediated protection of brain after experimental cerebral ischemia in rat. Brain Res 1096:196-203.
35. Parada CA, Tambeli CH, Cunha FQ, Ferreira SH (2001) The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience 102:937-944.
36. Picolo G, Giorgi R, Cury Y (2000) δ-Opioid receptors and nitric oxide mediate the analgesic effect of Crotalus durissus terrificus snake venom. Eur J Pharmacol 391:55-62.
37. Ren K, Dubner R (1999) Central nervous system plasticity and persistent pain. J Orofac Pain 13:155-163.
38. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK (1998) The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391:79-82.
39. + channels. Br J Pharmacol 129:110-114.
40. Rodrigues LL, Oliveira MC, Pelegrini-da-Silva A, de Arruda Veiga MC, Parada CA, Tambeli CH (2006) Peripheral sympathetic component of the temporomandibular joint inflammatory pain in rats. J Pain 7:929-936.
41. Roveroni RC, Parada CA, Cecilia M, Veiga FA, Tambeli CH (2001) Development of a behavioral model of TMJ pain in rats: the TMJ formalin test. Pain 94:185-191.
42. Sachs D, Cunha FQ, Ferreira SH (2004) Peripheral analgesic blockade of hypernociception: activation of arginine/NO/cGMP/protein kinase G/ATP-sensitive K+ channel pathway. Proc Natl Acad Sci U S A 101:3680-3685.
43. Schoonjans K, Martin G, Staels B, Auwerx J (1997) Peroxisome proliferators activated receptors, orphans with ligands and functions. Curr Opin Lipidol 8:159-166.
44. Soares AC, Leite R, Tatsuo MA, Duarte ID (2000) Activation of ATPsensitive K(+) channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. Eur J Pharmacol 400:67-71.
45. Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, Earley TJ, Hergarden AC, Andersson DA, Hwang SW, McIntyre P, Jegla T, Bevan S, Patapoutian A (2003) ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112:819-829.
46. Straus DS, Glass CK (2001) Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 21:185-210.
47. Takahashi N, Mizuno Y, Kozai D, Yamamoto S, Kiyonaka S, Shibata T, Uchida K, Mori Y (2008) Molecular characterization of TRPA1 channel activation by cysteine-reactive inflammatory mediators. Channels 2:287-298.
48. Tambeli CH, Oliveira MC, Clemente JT, Pelegrini-da-Silva A, Parada CA (2006) A novel mechanism involved in 5-hydroxytryptamineinduced nociception: the indirect activation of primary afferents. Neuroscience 141:1517-1524.
49. Voog O, Alstergren P, Leibur E, Kallikorm R, Kopp S (2000) Immediate effects of the serotonin antagonist granisetron on temporomandibular joint pain in patients with systemic inflammatory disorders. Life Sci 68:591-602.
50. Widenfalk B, Wiberg M (1990) Origin of sympathetic and sensory innervation of the temporo-mandibular joint. A retrograde axonal tracing study in the rat. Neurosci Lett 109:30-35.
51. Yoshino K, Kawagishi S, Amano N (1998) Morphological characteristics of primary sensory and post-synaptic sympathetic neurones supplying the temporomandibular joint in the cat. Arch Oral Biol 43:668-679.
52. Yu K, Bavona W, Kallen CB, Harding HP, Ravera CP, McMahon G, Brown M, Lazar MA (1995) Differential activation of peroxisome proliferator- activated receptors by eicosanoids. J Biol Chem 270: 23975-23983.
53. Yu XM, Sessle BJ, Hu JW (1993) Differential effects of cutaneous and deep application of inflammatory irritant on mechanoreceptive field properties of trigeminal brain stem nociceptive neurons. J Neurophysiol 70:1704-1707.
54. Zhou Q, Imbe H, Dubner R, Ren K (1999) Persistent Fos protein expression after orofacial deep or cutaneous tissue inflammation in rats: implications for persistent orofacial pain. J Comp Neurol 412:276-291.
55. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110.
56. 2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. J Immunol 171:6827-6837.
57. Zingarelli B, Cook JA (2005) Peroxisome proliferator-activated receptor-γ is a new therapeutic target in sepsis and inflammation. Shock 23:393-399.